PCNA and osteosarcoma: In 1997, Shiraishi et al[17] first performed immunohistochemical staining of osteosarcoma specimens with an anti-PCNA monoclonal antibody to describe utility of the PCNA labeling index for predicting prognosis in osteosarcoma.